A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16234567

J. Natl. Cancer Inst. 2005 Oct 19 97 20 1532-8

Download in:

View as

Triples

General Info

PMID
16234567